Michael John Knabel

Michael Knabel practices at Ascension Columbia St. Mary's Hospital - Behavioral Health - Ozaukee in Mequon, Wisconsin.

Michael Knabel's NPI, 1295231769, was assigned on April 3, 2018. Michael Knabel graduated from Medical College of Wisconsin in 2018. Michael Knabel holds Wisconsin license 82136.

Michael Knabel's primary practice is Ascension Columbia St. Mary's Hospital - Behavioral Health - Ozaukee, at 13111 North Port Washington Road, Mequon, WI 53097. The practice phone is (262) 243-6127.

Michael Knabel's primary practice is Ascension Columbia St. Mary's Hospital - Behavioral Health - Ozaukee in Mequon, Wisconsin. Michael Knabel is also affiliated with Ascension Columbia St. Mary's Hospital - Milwaukee Campus. The medical group on file is Ascension Columbia St. Mary's Hospital - Milwaukee Campus. Dmand AI also links Michael Knabel to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Knabel practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Michael Knabel's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Michael Knabel's licenses on file in 3 states: Wisconsin, Illinois and South Carolina.

CMS data shows 1,179 Medicare services from Michael Knabel across 11 procedure codes in 2024, for 240 Medicare patients. Medicare paid $44,073 for them. Every service was in an office.

CMS counts 240 Medicare patients who saw Michael Knabel in 2024. The largest group is 65 to 74, with 112 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 9% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Michael Knabel's median patient age at 68, with 46% women.

In 2024, Michael Knabel wrote 726 Medicare Part D claims for 264 patients. 96% of them were for generic drugs. CMS names the drug for 554 of them, across 11 drugs with 11 or more claims each, at $13,900 in total drug cost. In 2023, CMS named 89 claims across 4 drugs.

Michael Knabel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 221 procedures of removal of skin lesions by Michael Knabel, more than 80% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Michael Knabel, published from 2016 to 2022. 2022 was the busiest year, with 2. The most frequent topics are Cough and Laryngopharyngeal Reflux. Michael Knabel has published most often in Ear Nose Throat J. Michael Knabel's most frequent co-authors are Anna B. Corey, MD, Paul Martin Knechtges, MD and Eden Louise Pappo Lake, MD.

CMS Open Payments shows 28 general payments to Michael Knabel from 8 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 96% of the total. Sanofi and Genzyme US Companies paid the most, $665.

Michael Knabel graduated from Medical College of Wisconsin in 2018.